During the past decade, Fundacion Estudios Clinicos conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Estudios Clinicos" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Estudios Clinicos" are "Atopic Dermatitis" (1 trials), "Breast Neoplasms" (1 trials), "Covid19" (1 trials), "Eczema" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Fundacion Estudios Clinicos" in a lesser frequency.

Most popular intervention types in "Fundacion Estudios Clinicos" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Anastrozole" (1 trials), "Exemestane" (1 trials), "Imlunestrant" (1 trials) and "LYT-100" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Estudios Clinicos" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Estudios Clinicos". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fundacion Estudios Clinicos, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Estudios Clinicos, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".